{"disease":{"id":"aneurysmal-subarachnoid-haemorrhage","name":"aneurysmal subarachnoid haemorrhage"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04356599","title":"Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Using Dynamic 18F-FDG PET/CT","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05259514","title":"CytoSorb SAH Trial","phase":"NA","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Emanuela Keller","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}